The forthcoming Apple Watch may not include all of the health-monitoring benefits we previously hoped for.
According to a report last week by the Wall Street Journal, Apple Watch production problems have arisen with some of the wearable’s originally-planned features. If the story is accurate, the company has had to drop plans to include, namely, blood-pressure, heart rate, and stress level tracking in Apple Watch 1.0.
CNet points to inconsistent results with these three features, something that Apple has been unable to overcome thus far. There’s also, reportedly, a concern with the wearable crossing-over to “medical advice” territory; which would require the product to potentially undergo FDA approval.
The product should still track a wearer’s activity level (similar to FitBit), as this functionality is already included in the iPhone 6 & 6-Plus. Apple Pay will also likely to be integrated into the wearable — and, once the finished-version of the Apple Watch gets into the hands of developers, it will be interesting to see what apps and features get added later on.
Still, this news comes as somewhat of a disappointment. Should it prove true, the Apple Watch may not be as appealing to those on-the-fence about the product’s rumored entry price of $349. The Apple Watch will require the owner to have another iOS-powered device to fully realize its full potential; and, the nightly charging limitation (also likely to be a reality) offers fitness-minded folks a little reason to be weary — especially as companies, such as the aforementioned FitBit, have cheaper wearables on the market with longer battery life & more features.
We should learn more about just what (or what not) will be included in the Apple Watch’s initial release soon; with the April ship date looming, pre-orders are likely to start within the next few weeks.